These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 4729722

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of high dose spironolactone and chlorthalidone in essential hypertension: relation to plasma renin activity and plasma volume.
    Hunyor SN, Zweifler AJ, Hansson L, Schork MA, Ellis C.
    Aust N Z J Med; 1975 Feb; 5(1):17-24. PubMed ID: 1057909
    [Abstract] [Full Text] [Related]

  • 3. Intrapatient comparison of treatment with chlorthalidone, spironolactone and propranolol in normoreninemic essential hypertension.
    Drayer JI, Kloppenborg PW, Festen J, van't Laar A, Benraad TJ.
    Am J Cardiol; 1975 Oct 31; 36(5):716-21. PubMed ID: 1103606
    [Abstract] [Full Text] [Related]

  • 4. Comparison of chlorthalidone and spironolactone in low--renin essential hypertension.
    Kreeft JH, Larochelle P, Ogilvie RI.
    Can Med Assoc J; 1983 Jan 01; 128(1):31-4. PubMed ID: 6336600
    [Abstract] [Full Text] [Related]

  • 5. Treatment of low-renin essential hypertension. Comparison of spironolactone and a hydrochlorothiazide-triamterene combination.
    Douglas JG, Hollifield JW, Liddle GW.
    JAMA; 1974 Feb 04; 227(5):518-21. PubMed ID: 4589187
    [No Abstract] [Full Text] [Related]

  • 6. Studies on essential hypertension with suppressed plasma renin activity: sodium excretion pattern on salt restriction and effects of spironolactone on blood pressure and plasma renin activity.
    Uchida K, Morimoto S, Takeda R, Murakami M.
    Jpn Circ J; 1972 Dec 04; 36(12):1301-11. PubMed ID: 4679217
    [No Abstract] [Full Text] [Related]

  • 7. Spironolactone as a nonspecific treatment for primary aldosteronism.
    Bravo EL, Dustan HP, Tarazi RC.
    Circulation; 1973 Sep 04; 48(3):491-8. PubMed ID: 4726231
    [No Abstract] [Full Text] [Related]

  • 8. [Correlations between blood pressure, blood volume and plasma renin during therapy with diuretics in essential hypertension. Comparison between the mineralocorticoid antagonist spironolactone and the "loop" diuretic mefruside].
    Beretta-Piccoli C, Weidmann P, de Châtel R, Hirsch D, Reubi FC.
    Schweiz Med Wochenschr; 1977 Jan 29; 107(4):104-15. PubMed ID: 834983
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Evaluation of the plasma renin activity and urinary aldosterone excretion in patients with essential hypertension treated with spironolactone. Note II].
    Bompiani GD, Scaduto P, Galluzzo A, Donatelli M, Morici ML, Mangano MT, Messina L.
    Minerva Cardioangiol; 1976 May 29; 24(5):352-9. PubMed ID: 1012481
    [No Abstract] [Full Text] [Related]

  • 11. Diuretic therapies in low renin and normal renin essential hypertension.
    Brooks CS, Johnson CA, Kotchen JM, Kotchen TA.
    Clin Pharmacol Ther; 1977 Jul 29; 22(1):14-20. PubMed ID: 326459
    [Abstract] [Full Text] [Related]

  • 12. Plasma renin activity in the diagnosis of primary aldosteronism: failure to distinguish primary aldosteronism from essential hypertension.
    Jose A, Kaplan NM.
    Arch Intern Med; 1969 Feb 29; 123(2):141-6. PubMed ID: 5812600
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Use of spironolactone and indapamide in the treatment of low-renin arterial hypertension].
    Naudzhunas A, Bagdonas G, Yankauskene L, Kazanavichus G.
    Ter Arkh; 2006 Feb 29; 78(2):61-4. PubMed ID: 16613101
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Failure of aspirin to antagonize the antihypertensive effect of spironolactone in low-renin hypertension.
    Hollifield JW.
    South Med J; 1976 Aug 29; 69(8):1034-6. PubMed ID: 785608
    [Abstract] [Full Text] [Related]

  • 18. Differential effects of chlorthalidone versus spironolactone on muscle sympathetic nerve activity in hypertensive patients.
    Menon DV, Arbique D, Wang Z, Adams-Huet B, Auchus RJ, Vongpatanasin W.
    J Clin Endocrinol Metab; 2009 Apr 29; 94(4):1361-6. PubMed ID: 19158191
    [Abstract] [Full Text] [Related]

  • 19. [Spironolactone combined with chlorthalidone in the treatment of essential arterial hypertension].
    Gragnoli G, Puccetti F, Tanganelli I, Favilli R, Nami R.
    Minerva Med; 1975 Apr 21; 66(30):1412-6. PubMed ID: 1143685
    [Abstract] [Full Text] [Related]

  • 20. Similar effects of hydrochlorothiazide and spironolactone on plasma renin activity in essential hypertension.
    Acchiardo S, Dustan HP, Tarazi RC.
    Cleve Clin Q; 1972 Apr 21; 39(4):153-62. PubMed ID: 4660197
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.